Inventor profile of:

Jacqueline M. Mason

City:

Toronto

Country:

Canada

Published Applications:

17

Last publication date:

2025-02-13

Top Assignees for applications by Jacqueline M. Mason

The entities that hold a legal rights for patent applications filed by inventor Mason Jacqueline M.:

Recent patent applications by Mason Jacqueline M.

Jacqueline M. Mason from Toronto, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-13
US20250049787A1
Human necessities

TREATMENT FOR ACUTE MYELOID LEUKEMIA OR LYMPHOMA

#2 | 2024-05-09
US20240150462A1
Chemistry; metallurgy

LILRB1 AND LILRB2-BINDING MOLECULES AND USES THEREFOR

#3 | 2023-12-07
US20230390294A1
Human necessities

COMBINATION THERAPIES FOR INHIBITION OF TTK PROTEIN KINASE

#4 | 2023-06-01
US20230165871A1
Human necessities

COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4

#5 | 2023-05-11
US20230144869A1
Human necessities

METHODS FOR TREATING CYTOKINE RELEASE SYNDROME

#6 | 2023-01-12
US20230010772A1
Human necessities

TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME

#7 | 2022-05-19
US20220153834A1
Chemistry; metallurgy

TSG-6 ANTIBODIES AND USES THEREFOR

#8 | 2022-03-24
US20220089725A1
Chemistry; metallurgy

FCMR-binding molecules and uses thereof

#9 | 2022-03-24
US20220089723A1
Chemistry; metallurgy

LILRB3-BINDING MOLECULES AND USES THEREFOR

#10 | 2021-08-26
US20210261554A1
Chemistry; metallurgy

RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

#11 | 2021-03-04
US20210060026A1
Human necessities

Combination therapies for inhibition of polo-like kinase 4

#12 | 2020-07-23
US20200230144A1
Human necessities

Combination therapies for inhibition of TTK protein kinase

#13 | 2019-07-25
US20190225617A1
Chemistry; metallurgy

RIPK2 inhibitors and method of treating cancer with same

#14 | 2018-10-04
US20180282335A1
Chemistry; metallurgy

RIPK2 inhibitors and method of treating cancer with same

#15 | 2016-09-01
US20160250220A1
Human necessities

Treatment for pancreatic cancer

#16 | 2015-07-02
US20150182504A1
Human necessities

Methods of targeting PTEN mutant diseases and compositions therefor

#17 | 2013-05-16
US20130123273A1
Human necessities

Methods of targeting PTEN mutant diseases and compositions therefor

InventorID:

249262 ⎘